Reviews

Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology
Yanchen Zhou, Hweixian L Penny, Mark A Kroenke, Bianca Bautista, Kelly Hainline, Lynette S Chea, Jane Parnes, Daniel T Mytych

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004225; DOI: 10.1136/jitc-2021-004225
Tumor-associated macrophages in multiple myeloma: advances in biology and therapy
Jennifer Sun, Chaelee Park, Nicole Guenthner, Shannon Gurley, Luna Zhang, Berit Lubben, Ola Adebayo, Hannah Bash, Yixuan Chen, Mina Maksimos, Barbara Muz, Abdel Kareem Azab

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e003975; DOI: 10.1136/jitc-2021-003975
The use of oncolytic virotherapy in the neoadjuvant setting
Raquela J Thomas, Eric Bartee

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004462; DOI: 10.1136/jitc-2021-004462
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y Chiang, Ira Mellman

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004711; DOI: 10.1136/jitc-2022-004711
To go or not to go? Biological logic gating engineered T cells
Rebecca C Abbott, Hannah E Hughes-Parry, Misty R Jenkins

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004185; DOI: 10.1136/jitc-2021-004185
Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy
Yeonggyeong Park, Min Jeong Kim, Yoonhee Choi, Na Hyun Kim, Leeseul Kim, Seung Pyo Daniel Hong, Hyung-Gyo Cho, Emma Yu, Young Kwang Chae

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003566; DOI: 10.1136/jitc-2021-003566
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy
Ryan C. Augustin, Robert D. Leone, Aung Naing, Lawrence Fong, Riyue Bao, Jason J. Luke

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e004089; DOI: 10.1136/jitc-2021-004089
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition
Meagan-Helen Henderson Berg, Sonia Victoria del Rincón, Wilson H Miller

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003551; DOI: 10.1136/jitc-2021-003551
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
Olivier Michielin, Aly-Khan Lalani, Caroline Robert, Padmanee Sharma, Solange Peters

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003024; DOI: 10.1136/jitc-2021-003024
Immuno-oncology trends: preclinical models, biomarkers, and clinical development
Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Giuseppe Curigliano, Steven Anderson

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003231; DOI: 10.1136/jitc-2021-003231

Main menu

Reviews

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Reviews

Pages